Biblio

Export 624 results:
Author Title Type [ Year(Desc)]
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
2024
A. Aljassabi, Zieneldien, T., Kim, J., Regmi, D., and Cao, C., “Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects.”, J Alzheimers Dis, vol. 98, no. 3, pp. 755-772, 2024.
H. M. Lalive, Griffa, A., Carlier, S., Nasuti, M., Di Noto, T., Maréchal, B., Rouaud, O., and Allali, G., “Amnestic Syndrome in Memory Clinics: Similar Morphological Brain Patterns in Older Adults with and without Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 1, pp. 333-343, 2024.
K. Noorda, Noorda, K., Sabbagh, M. N., Bertelson, J., Singer, J., and Decourt, B., “Amyloid-Directed Antibodies: Past, Present, and Future.”, J Alzheimers Dis, vol. 101, no. s1, pp. S3-S22, 2024.
R. W. B. Love, “Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-β Plaques in Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1235-1241, 2024.
R. Pluta, Bogucka-Kocka, A., Bogucki, J., Kocki, J., and Czuczwar, S. J., “Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer's Disease with 2-Year Survival.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1375-1383, 2024.
D. A. Loeffler, “Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems.”, J Alzheimers Dis, vol. 100, no. 2, pp. 379-411, 2024.
T. Nagata, Nakajima, S., Kito, S., and Shinagawa, S., “The Association Between Distinct Delusional Ideations and Depressive Symptoms in Alzheimer's Disease: A Re-Analysis of CATIE-AD.”, J Alzheimers Dis, vol. 101, no. 2, pp. 661-670, 2024.
J. Ren, Yu, Y., Wang, Y., Dong, Y., and Shen, X., “Association Between Urinary Glyphosate Exposure and Cognitive Impairment in Older Adults from NHANES 2013-2014.”, J Alzheimers Dis, vol. 97, no. 2, pp. 609-620, 2024.
X. - X. Zhang, Wang, H. - R., Hu, Y. - Z., Sun, H. - M., Feng, Y. - X., and Jia, J. - J., “Association of Vitamin D Levels with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Studies.”, J Alzheimers Dis, vol. 98, no. 2, pp. 373-385, 2024.
Z. Li, Fan, Z., and Zhang, Q., “The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 98, no. 1, pp. 13-32, 2024.
J. R. M. Coimbra, Resende, R., Custódio, J. B. A., Salvador, J. A. R., and Santos, A. E., “BACE1 Inhibitors for Alzheimer's Disease: Current Challenges and Future Perspectives.”, J Alzheimers Dis, vol. 101, no. s1, pp. S53-S78, 2024.
I. J. Sible and Nation, D. A., “Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1851-1860, 2024.
W. B. Grant, “A Brief History of the Progress in Our Understanding of Genetics and Lifestyle, Especially Diet, in the Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. s1, pp. S165-S178, 2024.
Y. Zeng, Cao, S., Pang, K., Tang, J., and Lin, G., “Causal Association Between Sepsis and Neurodegenerative Diseases: A Bidirectional Two-Sample Mendelian Randomization Study.”, J Alzheimers Dis, vol. 97, no. 1, pp. 229-237, 2024.
P. P. Chum, Bishara, M. A., Solis, S. R., and Behringer, E. J., “Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation.”, J Alzheimers Dis, vol. 99, no. s2, pp. S187-S234, 2024.
C. Rosario Ilardi, Menichelli, A., Michelutti, M., Cattaruzza, T., Federico, G., Salvatore, M., Iavarone, A., and Manganotti, P., “On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 101, no. 1, pp. 293-308, 2024.
I. Terao and Kodama, W., “Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease”, J Alzheimers Dis, vol. 98, no. 3, pp. 825-835, 2024.
N. Puentes-Díaz, Chaparro, D., Reyes-Marquez, V., Morales-Morales, D., Flores-Gaspar, A., and Alí-Torres, J., “Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S383-S396, 2024.
A. Mahzarnia, Lutz, M. W., and Badea, A., “A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.”, J Alzheimers Dis, vol. 97, no. 2, pp. 635-648, 2024.
N. Vaishnav, Gonzalez, R., Karunungan, K., Tyler, A., Zheng, W., and Arias, J. J., “Creating an Unprotected Class: Addressing Legal Risks in the Era of Biologically-Defined Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 1, pp. 187-195, 2024.
C. E. Finch and Burstein, S. M., “Dementia in the Ancient Greco-Roman World Was Minimally Mentioned.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1581-1588, 2024.
M. S. Weinberg, He, Y., Kivisäkk, P., Arnold, S. E., and Das, S., “Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S355-S365, 2024.
H. Shimada, Doi, T., Tsutsumimoto, K., Makino, K., Harada, K., Tomida, K., and Arai, H., “Elevated Risk of Dementia Diagnosis in Older Adults with Low Frequencies and Durations of Social Conversation.”, J Alzheimers Dis, vol. 98, no. 2, pp. 659-669, 2024.
X. Liang, Wang, Y., Li, S., Fan, J., Zhou, F., Li, X., Li, S., and Li, Y., “Enhancing Rab7 Activity by Inhibiting TBC1D5 Expression Improves Mitophagy in Alzheimer's Disease Models.”, J Alzheimers Dis, vol. 100, no. 1, pp. 279-296, 2024.
S. Hermes, Cady, J., Armentrout, S., O'Connor, J., Holdaway, S. Carlson, Cruchaga, C., Wingo, T., and Greytak, E. McRae, “Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1425-1440, 2024.

Pages